Action Behavior Centers Celebrates 2026 Graduates, Sharing Family Stories and Research on School Transition Outcomes

September 8, 2026 11:55 AM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), is celebrating the children who graduated from ABA therapy in 2026. For many families, graduation marks the end of early intervention as their child transitions into the classroom.2025 research from the Action Institute for Outcomes Research (AIoR), ABC's research arm led by...

Read more

Croí Health Hospice Residence Renamed to Include Barbara Roche

September 8, 2026 11:15 AM

On September 8, Croí Health officially unveils a new sign renaming the Pat Roche Hospice Home in Hingham, MA, to the Barbara and Pat Roche Hospice Home. The change honors the generosity of the couple, co-founders of the Roche Bros. supermarket chain, who helped make the residence possible.The Pat Roche Hospice Home first opened in 2013 as the region's first hospice residence, named for Patrick Roche following his passing in 2012. The...

Read more

GenHealth.ai Raises $16.5 Million Series A to Build AI Agents That Run the Medical Back Office

September 8, 2026 11:00 AM

GenHealth.ai, the healthcare AI company building AI agents that run the medical back office, today announced a $16.5 million Series A led by Flare Capital Partners. Existing investors Craft Ventures and Obvious Ventures participated, along with new investors Eniac Ventures, InHealth Ventures, Epsilon Health Investors, and ARTIS. The round brings GenHealth's total funding to $30 million.The United States spends about $1 trillion a year on...

Read more

Sacred Connection Unveils Ancestral Flow-State Priming Tool for the Biohacking and Performance Community

September 8, 2026 10:00 AM

In the pursuit of peak mental performance and seamless flow states, Sacred Connection today introduced an ancestral, direct-trade botanical preparation engineered for precision state control and rapid somatic alignment.While conventional neurohacking relies heavily on chemical cognitive enhancers, biohackers and high-performers are increasingly turning toward somatic tools that train immediate focus and state transitions. Traditional Hapé...

Read more

Commitment to Helping Communities Thrive: DaVita Community Care Report 2025

September 8, 2026 9:35 AM

DaVita's care network reaches people in every corner of the U.S. as well as 14 countries around the world. In every community the comprehensive kidney care provider touches, DaVita extends beyond offering outstanding healthcare services to give back and promote kidney health.How does DaVita work with the American Diabetes Association?Chronic kidney disease is common in people with both type 1 and type 2 diabetes and can lead to kidney problems....

Read more

StimCell Energetics Engages Stonegate Capital Markets as Non-Exclusive Advisor for Strategic Capital Market Transactions

September 8, 2026 9:15 AM

StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to announce that it has entered into an Advisory Services Agreement with Stonegate Capital Markets, Inc. ("Stonegate"), a Texas corporation, pursuant to which Stonegate will act as the Company's non-exclusive advisor.Pursuant to the Advisory Services Agreement effective August...

Read more

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

September 8, 2026 9:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it has changed its corporate name from "Aspire Biopharma Holdings, Inc." to "Aspire-Lakewood Holdings, Inc." The name change is effective upon the filing of a Certificate of Amendment to the Company's Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's ticker symbol, "ASBP", will remain unchanged.Kraig...

Read more

Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

September 8, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Neonorm Dog is now available on Amazon. A new extension of Jaguar's Neonorm franchise for companion and production animals, Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool consistency and GI fluid balance in dogs."Making Neonorm Dog available to pet owners through Amazon is a key component of...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Shows Investors a Multi-Platform Company: AI Health, Enterprise Vision, Consumer Apps, and Revenue-Generating Subsidiaries

September 8, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today outlined the breadth of its operating and development portfolio - a reminder that the Company is not a single-product story. MDCE's strategy is to apply proprietary AI vision and software development across several markets at once. Some platforms are in active development and testing. Others already generate operating activity through wholly owned subsidiaries. Together they form a diversified...

Read more

Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

September 8, 2026 8:40 AM

Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announces today an offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.S.$250 million aggregate principal amount (the "Maximum Tender Amount") of the Company's 2.032% Senior Notes due 2030 (the "Notes") from each registered...

Read more

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

September 8, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses in the Democratic Republic of Congo ("DRC") was successfully registered in the Pan African Clinical Trials Registry (pactr.samrc.ac.za) database. The unique...

Read more

What Women Want From Weight Management Support, and Why It Matters

September 8, 2026 8:30 AM

Historically, weight management has been framed as a matter of diet, exercise and willpower. But for many women, the experience is far more complex.From reproductive years through menopause and beyond, hormonal changes, life transitions and evolving health priorities can influence how women gain, lose and maintain weight. These factors can shape not only weight-related outcomes, but also overall well-being, confidence and long-term health.That's...

Read more

Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026

September 8, 2026 8:00 AM

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that its Chief Executive Officer, Jeb Besser, will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026.iAccess Alpha Virtual Conference Details:Dates: September 15-16,...

Read more

Who Does the Best Facelift in Florida?

September 8, 2026 6:00 AM

Facelift surgery has evolved beyond a single surgical approach, with different techniques used to address changes in facial skin and underlying tissues. For patients researching who does the best facelift in Florida, Dr. Alberico J. Sessa of Sarasota Surgical Arts performs several facelift procedures based on the extent and location of facial aging.With more than 18 years of cosmetic surgery experience and over 25,000 completed surgeries, Dr....

Read more

Who is the Best Female Cosmetic Surgeon in Florida?

September 8, 2026 6:00 AM

Patients researching cosmetic surgery in Florida often consider a surgeon's training, credentials and surgical experience. Dr. Winnie W. Lee of Sarasota Surgical Arts brings an uncommon background to cosmetic surgery, with board certifications in General Surgery and Cardiothoracic Surgery and fellowship training in cosmetic surgery. Honored with a 2025 Top Doctor Award, Dr. Winnie W. Lee is one of the best female cosmetic surgeons in Florida. ...

Read more

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

September 8, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,and Tollo Health, LLC ("Tollo"), a proprietary medical foods and nutraceutical manufacturer, today announced they have jointly entered into a partnership with the National Football League...

Read more

AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15

September 8, 2026 4:15 AM

AlzeCure Pharma AB ("AlzeCure" or "The Company") (STO:ALZCUR)(FRA:AC6) , which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, today announced that the company will participate in Aktiespararna's Aktiedagen in Stockholm event on September 15. CEO Martin Jönsson will give a corporate presentation and provide an update on the company's recently announced out-licensing and collaboration...

Read more

NOUVAG Receives FDA 510(k) Clearance for LipoSurg ARTIST, the Next Generation of Power-Assisted Liposuction

September 8, 2026 4:00 AM

NOUVAG AG today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for LipoSurg ARTIST®, its new power-assisted liposuction system for aesthetic body contouring.LipoSurg ARTIST® brings together infiltration, power-assisted liposuction and aspiration in one integrated system, developed around the surgical workflow and the needs of today's plastic surgeons.FDA clearance of LipoSurg ARTIST® marks an important...

Read more

Equitech-Bio Expands Reagent Portfolio with New IgG Offering and Publication-Backed Product Validation from Bioz

September 8, 2026 4:00 AM

Bioz, Inc., the scientific marketing platform that transforms peer-reviewed research into evidence-rich product experiences, today announced the continued expansion of its collaboration with Equitech-Bio, a trusted supplier of serum proteins, immunoglobulins, antisera, and other biological reagents for research, diagnostic development, and bioprocessing applications.As Equitech-Bio prepares to introduce a new reagent-grade IgG product, the...

Read more

BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study

September 8, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the advancement of its proprietary sublingual Everolimus oral dissolvable film ("ODF") program, initially targeting organ transplantation, with a comparative large-animal pharmacokinetic study.Everolimus test materials have been prepared for shipment to a preclinical...

Read more